Search Results - James L. Rubenstein
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
The Challenge of Primary Central Nervous System Lymphoma by Julia Carnevale, James L. Rubenstein
Published 2016Revisão -
2
-
3
-
4
Progress in central nervous system lymphomas by Chia-Ching J. Wang, Julia Carnevale, James L. Rubenstein
Published 2014Revisão -
5
-
6
-
7
-
8
How I treat CNS lymphomas by James L. Rubenstein, Neel K. Gupta, Gabriel N. Mannis, Amanda K. LaMarre, Patrick Treseler
Published 2013Artigo -
9
-
10
-
11
-
12
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms by Marc C. Mabray, Benjamin Cohen, Javier Villanueva-Meyer, Francisco Valles, Ramon Barajas, James L. Rubenstein, Soonmee Cha
Published 2015Artigo -
13
Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202) by James L. Rubenstein, Eric D. Hsi, Jeffrey L. Johnson, Sin‐Ho Jung, Megan O. Nakashima, Barbara Grant, Bruce D. Cheson, Lawrence D. Kaplan
Published 2013Artigo -
14
Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium by Chi-Chao Chan, James L. Rubenstein, Sarah E. Coupland, Janet L. Davis, J. William Harbour, Patrick B. Johnston, Nathalie Cassoux, Valérie Touitou, Justine R. Smith, Tracy T. Batchelor, José S. Pulido
Published 2011Revisão -
15
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment by James L. Rubenstein, Dan Combs, J. Rosenberg, Arthur Levy, Michael McDermott, Lloyd E. Damon, Robert J. Ignoffo, Kenneth Aldape, Arthur Shen, Dana Lee, Antonio J Grillo-López, Marc A. Shuman
Published 2002Artigo -
16
Protein Biomarker Identification in the CSF of Patients With CNS Lymphoma by Sushmita Roy, S Josephson, Jane Fridlyand, Jon Karch, Cigall Kadoch, Juliana Karrim, Lloyd E. Damon, Patrick Treseler, Sandeep Kunwar, Marc A. Shuman, Ted Jones, Christopher H. Becker, Howard Schulman, James L. Rubenstein
Published 2007Artigo -
17
Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI by Matthew J. Wieduwilt, Francisco Valles, Samar Issa, Caroline Behler, James Q. Hwang, Michael McDermott, Patrick Treseler, Joan M. O’Brien, Marc A. Shuman, Soonmee Cha, Lloyd E. Damon, James L. Rubenstein
Published 2012Artigo -
18
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell by Manuel Montesinos‐Rongen, Anna Brunn, Stefan Bentink, Katia Basso, Wei Keat Lim, Wolfram Klapper, Carlo Schaller, Guido Reifenberger, James L. Rubenstein, O. D. Wiestler, Rainer Spang, Riccardo Dalla‐Favera, Reiner Siebert, Martina Deckert
Published 2007Artigo -
19
Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma by James L. Rubenstein, Jane Fridlyand, Lauren E. Abrey, Arthur Shen, Jon Karch, Endi Wang, Samar Issa, Lloyd E. Damon, Michael D. Prados, Michael McDermott, Joan M. O’Brien, Chris Haqq, Marc Shuman
Published 2007Artigo -
20
Gene expression and angiotropism in primary CNS lymphoma by James L. Rubenstein, Jane Fridlyand, Arthur Shen, Ken Aldape, David G. Ginzinger, Tracy T. Batchelor, Patrick Treseler, Mitchel Berger, Michael McDermott, Michael D. Prados, Jon Karch, Craig Okada, William C. Hyun, Seema Parikh, Chris Haqq, Marc Shuman
Published 2006Artigo
Search Tools:
Related Subjects
Medicine
Lymphoma
Internal medicine
Primary central nervous system lymphoma
Oncology
Pathology
Biology
Central nervous system
Immunology
Surgery
Rituximab
Methotrexate
Physics
Radiology
Chemotherapy
Magnetic resonance imaging
Antibody
Cancer research
Cerebrospinal fluid
Effective diffusion coefficient
B cell
Bioinformatics
Cancer
Gastroenterology
Germinal center
Neuroscience
Nuclear medicine
Pediatrics
Radiation therapy
Retrospective cohort study